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Objective. The objective of this study was to examine the effects of iloprost and N-acetylcysteine (NAC) on ischemia-reperfusion
(IR) injuries to the gastrocnemius muscle, following the occlusion-reperfusion period in the abdominal aorta of rats. Materials
and Methods. Forty male Sprague-Dawley rats were randomly divided into four equal groups. Group 1: control group. Group 2 (IR):
aorta was occluded. The clamp was removed after 1 hour of ischemia. Blood samples and muscle tissue specimens were collected
following a 2-hour reperfusion period. Group 3 (IR + iloprost): during a 1-hour ischemia period, iloprost infusion was initiated
from the jugular catheter. During a 2-hour reperfusion period, the iloprost infusion continued. Group 4 (IR + NAC): similar to the
iloprost group. Findings. The mean total oxidant status, CK, and LDH levels were highest in Group 2 and lowest in Group 1. The
levels of these parameters inGroup 3 andGroup 4were lower compared toGroup 2 and higher compared toGroup 1 (𝑃 < 0.05).The
histopathological examination showed that Group 3 and Group 4, compared to Group 2, had preserved appearance with respect
to hemorrhage, necrosis, loss of nuclei, infiltration, and similar parameters. Conclusion. Iloprost and NAC are effective against
ischemia-reperfusion injury and decrease ischemia-related tissue injury.
1. Introduction
Ischemia is the absence or insufficiency of blood supply
to tissues due to various reasons. Hypoxic tissue damage
occurs as a result of ischemia. Long periods of ischemia
lead to a loss of cellular integrity and result in cellular
death. Reperfusion, on the other hand, is the return of the
blood supply to the tissue. During reperfusion, the release of
free oxygen radicals, especially from the polymorphonuclear
leukocytes (PMNL) that accumulate in the tissue, accelerates
tissue breakdown. This is referred to as reperfusion injury
[1]. Different biochemical methods are used to determine
tissue injury, and TAS and TOS are among the well-known
methods. Additionally, these markers were comprehensively
evaluated in the reports of previous experimental peripheral
ischemia studies [2].
Local and systemic effects that are caused by the ischemia-
reperfusion syndrome are frequently seen in surgery and
affect the postoperative morbidity and mortality. It is known
that ischemia-reperfusion injury develops in various tis-
sues, including skeletal muscle, heart, lung, central ner-
vous system, kidney, and gastrointestinal system. Acute
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ischemia-reperfusion injury in the lower extremities appears
particularly during temporary cross-clamp application to the
abdominal aorta or during unilateral/bilateral acute femoral
artery congestion [2–5]. During abdominal aorta surgery,
local tissue injury can occur in ischemic extremities and dis-
tant organ injury can occur in other regions. Local effects are
seen in distal regions of the clamp, veins, and muscle tissue,
whereas systemic effects are seen mainly in the brain, heart,
lung, kidneys, and other organs. In clinical practice, a clamp
is placed on the infrarenal aorta during abdominal aortic
aneurysm, Leriche syndrome, and aortoiliac diseases, and
the lower extremity stays ischemic until anastomosis is com-
pleted. Following anastomosis and the removal of the aortic
clamp, reperfusion of ischemic tissues occurs [3–5].
The objective of this study was to investigate the effects
of iloprost (a Pgl2 analog) and NAC on ischemia-reperfusion
injuries to the gastrocnemius muscle following an occlusion-
reperfusion period in infrarenal abdominal aorta of rats.
2. Materials and Methods
The study was approved by the Eskisehir Osmangazi
University Animal Experiments Local Ethics Committee
(26.04.2011, approval number 212/2011). Animals were pur-
chased from theMedical and Surgical Experimental Research
Center (MSERC). Forty male Sprague-Dawley rats (mean
weight 300–350 g) were divided into four equal groups (𝑛 =
10). Animals were kept in an environmentwith a 12:12 h light-
dark cycle and constant temperature (20–22C∘) and humidity
(45–50%). During the experiments, all animals were kept in
transparent cages, were fed with standard rat diet, and were
given tap water.
All animals were weighed before the procedures and
their body weights were recorded. After 8 hours of starva-
tion, all animals received 50mg/kg of ketamine hydrochlo-
ride anesthesia intramuscularly (Ketalar 50mg/mL flacon,
Pfizer). Median laparotomy was performed after achieving
the appropriate position and establishing vascular access.
Approximately 10mL of saline solution was injected into the
peritoneal space for fluid resuscitation. Infrarenal abdominal
aorta was explored by obtuse dissection. Low dose heparin
(100U/kg) (Nevparin 25000 IU 5mL flacon,Mustafa Nevzat)
was administered. An atraumatic microvascular clamp was
placed on the infrarenal abdominal aorta (Nova 12mm
Angle). To minimize heat and fluid loss, the abdominal cut
was closed with silk sutures. Following 1 hour of ischemia,
2 hours of reperfusion period was performed. During the
procedure, 0.9% saline solution (10mg/kg) was administered
intravenously to provide hydration. Aortic ischemia was
monitored with the loss of pulsation in the aorta after clamp-
ing; reperfusion was monitored by the presence of pulsation
in the aorta after clamp removal. In the control group,
laparotomy and infrarenal abdominal aorta dissection were
performed for the same time period; however, the ischemia-
reperfusion period was not performed. All animals were
sacrificed after reperfusion. Blood samples were collected
from the right ventricle, and tissue specimens were collected
from the gastrocnemius muscle. Muscle tissue specimens
were stored in 10% formaldehyde solution.
2.1. Experimental Groups
2.1.1. Control Group (Group 1) (𝑛 = 10). Laparotomy was
performed, but the aorta was not occluded. Saline solution
was injected into the abdomen, and the abdominal cut was
closed with a silk suture. One-hour ischemia and 2 hours of
reperfusion period, which was performed in other groups,
were completed.
2.1.2. Ischemia-Reperfusion Group (SHAM) (Group 2) (𝑛 =
10). The aorta was rotated with an obtuse dissection, and
an atraumatic microvascular clamp was placed.The presence
of pulsation under clamp was checked. Saline solution was
injected into the abdomen, and abdomen was closed with a
silk suture. After 1-hour ischemia, silk sutures were removed.
The microvascular clamp was removed, and the presence
of pulsation in the aorta was checked by palpation. Saline
solution was injected into the abdomen. Abdominal layers
were closed again. Following 2 hours of reperfusion period,
blood and tissue sampleswere collected, and the animalswere
sacrificed.
2.1.3. Ischemia-Reperfusion + Iloprost Group (Group 3) (𝑛 =
10). During a 1-hour ischemia period, 2mcg/kg/h iloprost
(Bayer Schering Pharma AG, Berlin-Wedding, Germany)
infusion was initiated from the jugular catheter at the
50th minute of ischemia [6]. The microvascular clamp was
removed after the ischemia period.The presence of a pulse in
the aorta was checked. Saline solution was injected into the
abdomen. Then, the abdomen was closed again, and iloprost
infusion continued throughout the 2 hours of the reperfusion
period. At the end of the procedure, blood and tissue samples
were collected, and the animals were sacrificed.
2.1.4. Ischemia-Reperfusion + NAC Group (Group 4) (𝑛 = 10).
Similar to the iloprost group, during the 1-hour ischemia
period, 20mg/kg NAC (Sandoz Ltd, Basel, Switzerland) was
administered as a bolus loading dose via the jugular catheter
at the 50th minute of ischemia [7]. Infusion was initiated at a
dose of 20mg/kg/h.
Drug dosages were determined according to previous
studies [6, 7].
2.2. Biochemical Analyses. Blood samples were kept at room
temperature for 30 minutes, and plasma samples were sep-
arated and were stored at −70C∘. Then, plasma samples
were allowed to thaw at room temperature. Total antioxi-
dant capacity (TAC), total antioxidant activity (TAA), total
antioxidant status (TAS), creatine kinase (CK), and lactate
dehydrogenase (LDH) levels weremeasured. Reactive oxygen
species are produced during metabolic and physiological
processes and harmful oxidative reactions can occur in
organisms that eliminate these molecules through enzymatic
and nonenzymatic reactions. Under certain circumstances,
the increase in oxidants and the decrease in antioxidants
cannot be prevented, and more than 100 disorders, such as
oxidative stress, develop.
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Antioxidant molecules prevent or eliminate these harm-
ful reactions. It is possible to measure serum or plasma con-
centrations of different antioxidants individually; however,
these measurements require a significant amount of time and
labor and involve expensive and complex techniques. Given
that the measurement of different antioxidant molecules
is not practical and the additive effects of antioxidants,
total antioxidant capacity is measured and has been named
differently, including total antioxidant capacity (TAC), total
antioxidant activity (TAA), and total antioxidant status
(TAS). The TAS measurement method is a fully automated
method developed by Erel and is capable of measuring the
total antioxidant capacity of the body against strong free
radicals [2, 8, 9].
2.3. Total Antioxidant Status (TAS). The test is based on
the reduction of the color intensity that is provided by the
blue-green ABTS+ (2.2󸀠-azinobis-3-ethylbenzothiazoline-6-
sulfonate) radical, upon the addition of antioxidants to the
medium. To produce the ABTS+ radical, ABTS is incubated
with metmyoglobin (HX-Fe+), a peroxidase, and H
2
O
2
. The
resulting ferryl myoglobin reacts with ABTS to produce the
ABTS+ radical.TheABTS+ radical is partially stable and has a
blue-green color. The color change is inhibited depending on
the amount of antioxidants in the sample.This color change is
measured in 600 nmwavelength. A vitamin E analog, Trolox,
was used as a standard in TAS measurement [2, 8].
2.4. Total Oxidant Status (TOS). The TOS measurement
method is a fully automated, colorimetric method developed
by Erel. The oxidant molecules within a sample oxidize the
ferrous ion-o-dianisidine complex to ferric ion.The presence
of glycerol accelerates the rate of this reaction approximately
threefold. Ferric ions form a colored complex with xylenol
orange in an acidic environment.The color intensity depends
on the amount of oxidant molecules within the sample and
is measured spectrophotometrically. Hydrogen peroxide is
used for calibration, and the results are expressed as 𝜇mol
H
2
O
2
equiv./L [2, 9].
2.5. Histopathological Examination of Muscle Tissues. The
gastrocnemius muscle samples were fixed in 10% neutral
formaldehyde solution. Then, the samples were dehydrated
in gradually increasing alcohol series, became transparent in
xylol, and embedded in paraffin. Five-micrometer-thick sec-
tionswere put onpoly-L-lysine-coated slides and stainedwith
hematoxylin and eosin. Tissue samples were visualized on a
photomicroscope (Olympus, with a DP70 digital camera).
Tissue injury was scored semiquantitatively as follows:
(0) no injury, (1) mild, (2) moderate, and (3) severe. Injury
was evaluated with respect to the following parameters: loss
of striation in muscle fibers, faint peripheral nuclei, necrosis,
cellular swelling, edema and fibrosis, leukocyte accumulation
in capillaries betweenmuscle fibers, congestion, hemorrhage,
and PMNL, monocyte, and macrophage infiltration.
2.6. Statistical Analysis. Kruskal-Wallis one-way variance
analysis was used to evaluate the differences between the
Table 1: Variance analysis of biochemical findings. Total antioxidant
status (TAS), Total Oxidant Status (TOS), creatine kinase (CK), and
lactate dehydrogenase (LDH).
Parameters Groups Mean ± standard deviation 𝑃 value
TAS
Group 1 1.764 ± 0.09
<0.05Group 2 1.065 ± 0.10
Group 3 1.349 ± 0.05
Group 4 1.275 ± 0.049
TOS
Group 1 10.57 ± 2.51
<0.05Group 2 56.73 ± 5.02
Group 3 27.52 ± 3.61
Group 4 39.92 ± 2.99
CK
Group 1 5082 ± 1056
<0.05Group 2 28738 ± 2117
Group 3 16117 ± 1720
Group 4 20942 ± 1549
LDH
Group 1 2231 ± 218
<0.05Group 2 6090 ± 406
Group 3 3937 ± 148
Group 4 4786 ± 313
groups. Tukey’smultiple comparison test was used to evaluate
the difference of each group from other groups. SPSS v.15.0
and Sigma Stat v.3.10 software were used for statistical analy-
sis. 𝑃 values <0.05 were considered statistically significant.
3. Findings
3.1. Biochemical Findings. Serum TAS, TOS, CK, and LDH
levels are shown in Table 1.
When the results were evaluated using the Kruskal-Wallis
one-way variance analysis, there was a significant difference
between all groups (𝑃 < 0.05) (Table 1).
Tukey’s multiple comparison test showed that the mean
TAS level was highest in Group 1 and lowest in Group 2.
In Group 3 and Group 4, the mean TAS levels were lower
compared to Group 1 but higher compared to Group 2 (𝑃 <
0.05). In addition, there was no significant difference between
Group 3 and Group 4 (𝑃 > 0.05) (Table 2).
The mean TOS, CK, and LDH levels were highest in
Group 2 and lowest inGroup 1. InGroup 3 andGroup 4, these
levels were lower compared to Group 2 but higher compared
to Group 1 (𝑃 < 0.05). When Group 3 and Group 4 were
compared, the mean TOS level was significantly lower in
Group 3 compared to Group 4 (𝑃 < 0.05).
3.2. Histopathological Findings. The results of the histological
examination in the control group and experimental groups
are shown in Table 2.
Tissues were stained with hematoxylin and eosin and
visualized on a photomicroscope (Olympus, equipped with
a DP70 digital camera).
The control group (Group 1) had normal muscle tissue
appearance (Figure 1). Peripheral nuclei inmuscle fibers were
not faint. Loss of striation in muscle fibers, cellular swelling,
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Table 2: Histological findings of all groups.
Control
group
I-R
group
Iloprost
group
NAC
group
Loss of striation 0 1 2 2
Uncertainties in the
peripheral nucleus 0 0 0 0 NS
Necrosis 0 2 1 1
Cellular swelling 0 1 0 1
Edema 0 2 1 2
Fibrosis 0 2 1 2
Leukocyte
accumulation in
capillaries
0 2 2 1
Congestion 0 2 2 1
Hemorrhage 0 0 0 0 NS
PMNL infiltration 0 3 1 1
Monocyte-macrophage
infiltration 0 2 1 1
NS: not significant.
Figure 1: Normal appearance of the gastrocnemius muscle in the
control group (H&E staining, bar 20 𝜇m, bar 10𝜇m).
necrosis, edema, and interfibrillar fibrosis were not observed.
There was no sign of leukocyte accumulation between the
interfibrillar capillaries. There were no signs of congestion or
hemorrhage. PMNL infiltration and monocyte-macrophage
infiltration were not observed.
In the ischemia-reperfusion group (Group 2), peripheral
nuclei were not faint. Loss of striation in muscle fibers and
cellular swelling were mild; necrosis, edema, and interfib-
rillar fibrosis were moderate. Leukocyte accumulation in
capillaries between the fibers was moderate. Congestion was
moderate, whereas hemorrhage was not observed. PMNL
infiltration was severe, and monocyte-macrophage infiltra-
tion was moderate (Figures 2 and 3).
In the iloprost group (Group 3), there was moderate
loss of striation in the muscle fibers. Peripheral nuclei were
not faint. There was no sign of cellular swelling in fibers,
whereas necrosis, edema, and fibrosis were moderate. Inter-
fibrillar leukocyte accumulation was moderate. Congestion
was moderate, and there was no sign of hemorrhage. PMNL
infiltration andmonocyte-macrophage infiltration were mild
(Figures 4 and 5).
In the NAC group (Group 4), loss of striation in muscle
fibers wasmoderate. Peripheral nuclei were not faint. Cellular
swelling and necrosis in fibers were mild; edema and fibrosis
were moderate. Leukocyte accumulation in interfibrillar cap-
illaries, congestion, and PMNL and monocyte-macrophage
Figure 2: Appearance of the gastrocnemius muscle in the ischemia-
reperfusion group: loss of striation inmuscle fibers, cellular swelling
and necrosis (star), edema betweenmuscle fibers and fibrosis (arrow
head) (H&E staining, bar 100𝜇m), edema between muscle fibers
(arrow), leukocyte infiltration and fibrosis, congestion in capillaries
(arrow head) (H&E staining, bar 50 𝜇m), cellular swelling and
necrosis (star), edema between muscle fibers, leukocyte infiltration
and fibrosis (arrow head), congestion in capillaries (H&E staining,
bar 20 𝜇m), cellular swelling and necrosis (star), edema between
muscle fibers (arrow head), monocyte and macrophage infiltration
(arrow), fibrosis, and congestion in capillaries (H&E staining, bar
10 𝜇m).
Figure 3: Appearance of the gastrocnemius muscle in the ischemia-
reperfusion group: edema between muscle fibers (arrow head),
leukocyte infiltration (arrow), congestion in capillaries and hem-
orrhage (star) (H&E staining, bar 200𝜇m), leukocyte infiltration
between muscle fibers (arrow), congestion in capillaries (star)
(H&E staining, bar 10 𝜇m), loss of striation in muscle fibers,
cellular swelling and necrosis (arrow head), edema between muscle
fibers (star), leukocyte infiltration, fibrosis, congestion in capillaries
(arrow) (H&E staining, bar 100𝜇m), leukocyte infiltration (arrow
head), fibrosis (star), and congestion in capillaries (arrow) (H&E
staining, bar 50 𝜇m).
infiltration were mild. There was no sign of hemorrhage
(Figure 6).
When we evaluated the results (Table 3), there was a
significant difference in the loss of striation in muscle fibers
between Group 1 and Group 2 (𝑃 < 0.05). A significant
difference was not observed between the other groups.
There was no significant difference in faint peripheral
nuclei between the groups.Whenwe compared the groups for
necrosis, cellular swelling, and edema there was a significant
difference between only Group 1 and Group 2 (𝑃 < 0.05).
There was a significant difference in fibrosis development
between Group 1 and Group 2 and Group 1 and Group 4 (𝑃 <
0.05).
There was a significant difference in leukocyte accumula-
tion in capillaries between Group 1 and Group 2 (𝑃 < 0.05).
There was a significant difference in congestion between
Group 1 and Group 2 and between Group 1 and Group 3.
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Figure 4: Appearance of gastrocnemius muscle in the iloprost
group: congestion in capillaries (arrow) and leukocyte infiltration
between muscle fibers (arrow head). Reduction in edema and fibro-
sis (star) (H&E staining, bar 100𝜇m), cellular swelling and necrosis
(star) (H&E staining, bar 20𝜇m), cellular swelling, necrosis (arrow
head), leukocyte infiltration in muscle fibers (arrow), fibrosis (star)
(H&E staining, bar 10𝜇m), leukocyte infiltration between muscle
fibers (arrow) andfibrosis (star), and congestion in capillaries (arrow
head) (H&E staining, bar 50𝜇m).
Figure 5: Appearance of gastrocnemius muscle in the iloprost
group: leukocyte infiltration between muscle fibers (arrow) and
fibrosis (arrow head) and congestion in capillaries (star) (H&E
staining, bar 10𝜇m).
There was no significant difference in hemorrhage
between the groups (𝑃 > 0.05).
Therewas a significant difference in PMNLandmonocyte
and macrophage infiltrations between Group 1 and Group 2
and between Group 2 and Group 4 (𝑃 < 0.05).
4. Discussion
Several studies have been carried out on the effect of iloprost
on skeletal muscle injury, heart injury, lung injury, and spinal
cord injury related to ischemia-reperfusion [6, 10–16]. Sac¸ar
et al. and Tekin et al. have shown that iloprost decreases
ischemia-reperfusion injury in muscle tissue [10, 13]. On
the other hand, Aytacoglu et al., Yakut et al., and Ozcan et
al. have shown that iloprost effectively decreases ischemia-
reperfusion injury in kidney tissue [14–16]. Myocardial tissue
injury and edema after ischemia/reperfusion were investi-
gated in a recent ischemia-reperfusion model by Caliskan
et al. They reported the possible protective role of ilo-
prost against ischemia-reperfusion injury in rat myocardium
histopathologically [6].
Iloprost is a PgI2 analog, has pharmacological features of
its endogenous precursor, and is more stable compared to its
Figure 6: Appearance of the gastrocnemius muscle in the NAC
group: loss of striation in muscle fibers, necrosis (star), and
fibrosis (arrow) (H&E staining, bar 50 𝜇m). Fibrosis (arrow head),
congestion in capillaries (star), and leukocyte infiltration (arrow)
(H&E staining, bar 20𝜇m). Loss of striation in muscle fibers
(star), cellular swelling, necrosis, congestion in capillaries (arrow
head), and leukocyte infiltration (arrow) (H&E staining, bar 20 𝜇m).
Interfibrillar fibrosis (arrow head) and congestion in capillaries
(star) (H&E staining, bar 10𝜇m).
endogenous precursor. Iloprost decreases neutrophil adhe-
sion. It prevents the release of free radicals from neutrophils,
thus decreasing the endothelial injury caused by neutrophils
during reperfusion. Endogenous PgI2 and nitric oxide are
autacoids that decrease vascular resistance and increase blood
flow. Similar to its endogenous precursor Pgl2, iloprost has
strong cytoprotective, antiaggregant, and vasodilator effects.
It disrupts the leukocyte-endothelial association by inhibiting
thrombocyte aggregation and decreasing the synthesis of
adhesion molecules. As a result, it increases microcirculation
and removes microvascular dysfunction. In addition, we
believe that iloprost effectively decreases muscle injury after
ischemia-reperfusion, by increasing tissue perfusion and
creating an endothelial-protective effect. Overall, iloprost
decreases ischemia-reperfusion-related muscle and distant
organ injury, similar to its endogenous precursor [17–19]. Our
findings indicate that iloprost causes a significant decrease in
ischemia-reperfusion injury in the muscle tissue.
NAC is used as an antioxidant as it increases intracel-
lular glutathione synthesis and also is a direct free oxygen
radical scavenger. Previous studies on the protective effects
of antioxidants against ischemia-reperfusion injury have also
increased our interest in antioxidants. In this study, we
preferred to use NAC as an antioxidant, as it is of low cost,
easily obtainable, and easy-to-use. In addition, its common
clinical use in the treatment of bronchopulmonary diseases
and bronchial secretion disorders was an incentive [20–24].
The first clinical observation on NAC was conducted by
Sochman andPeregrin in 1992.The authors described the first
use of NAC in a patient with acute myocardial infarction,
during their effort to protect left ventricle function with
pharmacological and mechanical treatment (thrombolysis
and percutaneous transluminal coronary angioplasty) and
to minimize infarct area [25]. This comprehensive treat-
ment led to the restoration of suppressed left ventricle
systolic function. In 1990, Sochman et al. demonstrated the
cardioprotective effect of NAC in dogs. The left anterior
descending coronary artery was tied for 2 hours before its
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Table 3: Comparison of histopathological results.
Parameters Groups Median(25–75 perc.)
Statistical
test (𝐻)
𝑃 value
Loss of
striation
Group 1 0 (0-0)
14.467 <0.05Group 2 1.5 (1-2)
Group 3 0 (0-1)
Group 4 1 (0-1)
Faint
peripheral
nuclei
Group 1 0 (0-0)
3.932 NSGroup 2 0 (0-0)
Group 3 0 (0-0)
Group 4 0 (0-0)
Necrosis
Group 1 0 (0-0)
19.172 <0.05Group 2 1.5 (1-2)
Group 3 0.5 (0-1)
Group 4 1 (0-1)
Cellular
swelling
Group 1 0 (0-0)
11.766 <0.05Group 2 1 (0-1)
Group 3 0 (0-0)
Group 4 0 (0-1)
Edema
Group 1 0.5 (0-1)
9.415 <0.05Group 2 2 (1–3)
Group 3 1 (0–2)
Group 4 1.5 (1-2)
Fibrosis
Group 1 0 (0-0)
17.759 <0.05Group 2 2 (1-2)
Group 3 1 (0–2)
Group 4 2 (1–3)
Leukocyte
accumulation
in capillaries
Group 1 0 (0-0)
13.064 <0.05Group 2 2 (2-2)
Group 3 0.5 (0–2)
Group 4 0 (0-1)
Congestion
Group 1 0 (0-0)
15.957 <0.05Group 2 2 (1-2)
Group 3 2 (2-3)
Group 4 1.5 (0–2)
Hemorrhage
Group 1 0 (0-0)
2.274 NSGroup 2 0 (0-0)
Group 3 0 (0-0)
Group 4 0 (0-0)
PMNL
infiltration
Group 1 0 (0-0)
21.263 <0.05Group 2 3 (3-3)
Group 3 1.5 (1-2)
Group 4 0 (0–2)
Monocyte-
macrophage
infiltration
Group 1 0 (0-1)
15.755 <0.05Group 2 2.5 (2-3)
Group 3 1 (0–2)
Group 4 0.5 (0–2)
NS: not significant.
first diagonal branch. At the end of this period, 100mg/kg of
NACwas administered to the treatment group. In conclusion,
the authors showed that NAC decreased the frequency of
ventricular arrhythmia after reperfusion and decreased the
infarct area [25, 26].
A study in 1996 showed that NAC can be used to
minimize ischemia-reperfusion syndrome in patients who
undergo abdominal aortic aneurysmectomy. In this study,
the patients received 150mg/kg of NAC 30 minutes before a
clamp was placed on the infrarenal aorta. Following clamp
removal, a significant increase in plasma reduced glutathione
(GSH) concentration was detected in these patients. More-
over, there was no change in plasma lipid peroxide levels [27].
Fischer et al. demonstrated that NAC administration
to dogs increases the solubility of myocardial edema after
cardioplegic arrest and cardiopulmonary by-pass and pro-
tects the systolic functions. Ten minutes prior to the car-
diopulmonary by-pass, NAC was administered at a bolus
dose of 100mg/kg, and then NAC infusion was continued
at a dose of 20mg/kg/h until 1 hour after cardiopulmonary
by-pass. In conclusion, following cardioplegic arrest and
cardiopulmonary by-pass, oxidative stress decreased in dogs
that were administered NAC [28].
Creatine kinase (CK), lactate dehydrogenase (LDH),
myoglobin, aspartate aminotransferase (AST), brain natri-
uretic peptide (BNP), atrial natriuretic peptide (ANP), car-
bonic anhydrase, troponin, and structural muscle proteins
are used to determine skeletal muscle injury. Among these
proteins, CK has the most frequently used enzyme in the
clinic and has the highest sensitivity to muscle injury. In
this regard, LDH is the second most common protein. CK
is responsible for ATP replenishment in muscle contraction
or transport systems. During each contraction cycle, the
skeletal muscle uses creatine phosphate to synthesize ATP.
Thus, the ATP levels in the muscle remain constant. CK
functions like a catalyzer in this reversible reaction. In the
present study, the plasma CK levels increased significantly
in the acute ischemia-reperfusion group.This finding reflects
the ischemia-reperfusion injury in the gastrocnemius muscle
following aortic occlusion-reperfusion. Several experimental
and clinical studies have shown that plasma CK levels
increase following acute ischemia-reperfusion [29–33]. We
found that plasma CK levels in IR + iloprost (Group 3)
and IR + NAC (Group 4) groups were significantly lower
compared to the IR group (Group 2). In a similar study,
the effect of iloprost on skeletal muscle injury after acute
ischemic-reperfusion was investigated, and the CK levels
were significantly lower in the IR + iloprost group compared
to the IR group.
Sac¸ar et al. also placed a cross-clamp on the infrarenal
abdominal aorta of rats for 3 hours and performed 1 hour
of reperfusion [10]. During reperfusion, iloprost infusion
was performed through the internal jugular vein, and blood
samples were collected after reperfusion.Then, CK and LDH
levels were analyzed, and similar to our study, the authors
found that the CK and LDH levels were significantly lower
in the IR + iloprost group compared to the IR group.
In our study, the significant decrease in plasma CK levels
in the IR + iloprost group is consistent with similar studies.
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Thus, it is possible to say that iloprost decreases skeletal
muscle injury after ischemia-reperfusion.
Oxidative stress depends on the disequilibrium between
reactive oxygen species and antioxidant defense systems and
the decrease in synthesis/activity of antioxidant enzymes
[2, 34, 35]. Individual measurement of oxidant molecules
is not a practical approach, and it is also known that
oxidant molecules exert a cumulative effect. In recent years,
cumulativemeasurement of oxidative stress parameters using
the TOSmethod is preferred rather thanmeasuring oxidative
stress parameters individually. Under physiological condi-
tions, the organism is protected from free oxygen radicals
by the antioxidant defense systems that metabolize these
radicals. It is well known that oxygen radicals that are
produced in ischemic tissues cannot be fully eliminated by
the antioxidant defense system, and free radical reactions are
among the major causes of tissue injury following ischemia
[36]. While it is possible to measure the antioxidant param-
eters individually, a kit has been developed to determine
the total antioxidant status levels. This provides information
about enzymatic and nonenzymatic antioxidants.
Aytacoglu et al. have performed occlusion-reperfusion in
infrarenal abdominal aorta of rats anddemonstrated that TAS
levels are higher in the iloprost-treated group compared to
the nontreated group [14]. In a similar study, Koksel et al.
demonstrated that iloprost leads to a significant increase in
TAS levels [11]. Koca et al., on the other hand, performed
arthroscopic knee surgery in patients and demonstrated
higher TAS levels and lower TOS levels in the NAC-treated
group [37].
Rabus et al. measured TAS and TOS levels in tissues and
plasma in rheumatic and degenerative heart valve diseases
and did not find a significant difference in tissue and plasma
TOS levels between the groups. While the authors did not
find a significant difference in plasma TOS levels, they
demonstrated that the tissue TAS levels were significantly
different [38]. Similarly, we only analyzed plasma TAS levels
and did not find a significant difference between the iloprost-
treated group and NAC-treated group. Considering the
degree of reflection of tissue injury to the periphery and the
possible differences between the tissues, it is clear that greater
knowledge and research are required on different factors that
affect TAS levels. Overall, biochemical findings showed that
iloprost and NAC were effective in reducing acute ischemia-
reperfusion injury, and iloprost was more effective compared
to NAC.
5. Conclusion
In conclusion, iloprost and N-acetylcysteine protect muscu-
lar tissue against ischemia-reperfusion, and the administra-
tion of these agents decreases ischemia-related tissue injury.
Nevertheless, other systematic effects and beneficial cellular
effects of these drugs should be investigated in further clinical
trials.
Limitations of Study
There are two major limitations that need to be addressed
regarding the present study. This study described
experimental I/R model in healthy rats. Therefore, these
results reflect acute results and these results should be
confirmed in human subjects. The other limitation concerns
the sample size of study. The sample size is small to give
the high statistical power. However, ethical approval could
be obtained to perform the study with a small number of
animals.
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